Author Archives: Elizabeth Hutchins

As PPMH Phase 1 funding reaches conclusion in mid-2026, we are excited to share the PPMH Phase 1 Impact Summary, developed as a high-level overview of the PPMH’s efforts and accomplishments to date. Highlighting key milestones and lasting impact, this overview reflects the powerful foundation we have established and the...

The Program for Precision Medicine in Health Care (PPMH) is supplying $3,000 pilot awards for services with the Clinical Genomic Analysis (GENYSIS) Core Facility. GENYSIS is a research service that collaborates with the BioSpecimen Processing (BSP) facility, the High-Throughput Sequencing Facility (HTSF), and the McLendon Molecular Genetics Laboratory (MGL), enabling...

In September 2024, the PPMH supplied a $300 conference award to Dr. Alissa Hutto (Clinical Assistant Professor, Department of Psychiatry) to attend the “Massachusetts General Hospital 4th Annual Conference on Precision Psychiatry: Innovation to Implementation”. Following the conference, the PPMH arranged a small summit with the goal of further generating...

As one of the newer core facilities at Carolina, GENYSIS aims to help researchers analyze whole exome and genome sequences — looking at a person’s entire genetic code. By working with existing core facilities, such as the BioSpecimen Processing Facility and High-Throughput Sequencing Facility, GENYSIS can provide a unique service...

A seminar and panel about working towards justice and genetic health literacy in clinical genomics and the complexity of supporting informed decision making by members of vulnerable or marginalized groups. Featured Speakers: Dr. Janeth Sanchez, PhD, MPH: Program Director for Health Equity at National Institutes of Health Dr. Janina Jeff,...

Despite comprising about 27% of the US population, the disability community has remained largely absent from diversity, equity and inclusion (DEI) efforts in precision medicine and genomics research. Research suggests that individuals with disabilities are willing to participate in precision medicine research, yet this group continues to be underrepresented. Reasons...

Efforts to expand access to genomic health and precision medicine have resulted in a proliferation of screening programs for healthy adult populations across the nation. Issues of fairness and equity abound in medicine and are a critical component of assessing implementation of these genomic health and precision medicine efforts. But...

Jeremy Purvis, PhD (Professor, Department of Genetics) has been awarded a new R01 grant for his project titled “Cell cycle paths as a framework for understanding drug resistance in tumor cell subpopulations” from the National Cancer Institute. The goal of this project is to investigate variability in tumor cell cycle...

As technologies and health interventions expand at a rapid rate in healthcare, many providers and patients desire quick and efficient incorporation of these new offerings in to practice. The field of implementation science can be critical in studying the barriers and facilitators to bring options previously available only in the...

Community engagement continues to be a critical component in genomic medicine and precision health research where the overall goal is to improve health outcomes of communities. The translation of findings into practice and implementation depends heavily on stakeholder engagement throughout the research process. In this seminar session on Wednesday, November...